Uncategorized
Kala Pharmaceuticals to Present at the Wedbush PacGrow Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary mucus-penetrating particle (MPP) technology, today announced that it will present at the 2018 Wedbush PacGrow Healthcare Conference in New York, NY. Mark Iwicki, Chairman and Chief Executive Officer at Kala Pharmaceuticals, will provide a corporate overview on Wednesday, August 15, 2018 at 9:45 AM ET.